Sangamo Therapeutics, Inc. (SGMO)
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.
$187.40M
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
431.00
Brisbane California, CALIFORNIA
Apr 06, 2000
-0.65
$-1.38
1.17
3.04
-123.87%
-0.27
-0.01
0.49
0.33
2.76
-113.57%
-99.89%
Similar stocks (4)
Alnylam Pharmaceuticals, Inc.
ALNY
Intellia Therapeutics, Inc.
NTLA
Editas Medicine, Inc.
EDIT
bluebird bio, Inc.
BLUE
ETF Exposure (19)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.664%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.04%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.007%
Schwab U.S. Small-Cap ETF
SCHA
0.0021771012%
Schwab U.S. Broad Market ETF
SCHB
1.821242e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Quantitative Funds - Vanguard Growth and Income Fund
VGIAX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Growth and Income Fund
VQNPX
0%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (4)
Alnylam Pharmaceuticals, Inc.
ALNY
Intellia Therapeutics, Inc.
NTLA
Editas Medicine, Inc.
EDIT
bluebird bio, Inc.
BLUE
ETF Exposure (19)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.664%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.04%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.007%
Schwab U.S. Small-Cap ETF
SCHA
0.0021771012%
Schwab U.S. Broad Market ETF
SCHB
1.821242e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Quantitative Funds - Vanguard Growth and Income Fund
VGIAX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Growth and Income Fund
VQNPX
0%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%